Commercial CRO Services & Regulatory Auditing | Eunoia Health
Public Beta Active: Operational Clinical Operations Hub Bridging South Florida & the Boston-Worcester Corridor.
M.D.-Led Clinical Operations & Regulatory Auditing

Capital-Efficient CRO Engine & FDA Validation Architecture

Eliminating legacy CRO bloat, opaque invoicing, and redundant software overhead. Led directly by Mohammad Alajarmeh, M.D., Eunoia Health provides precision trial management, regulatory auditing, and endpoint verification across South Florida and the Boston-Worcester Corridor.

Commercial Architecture

Flexible, Transparent Engagement Models

Match your trial cash flow directly with project scope and development phase.

Track 1

Embedded Senior Specialist

Flat Hourly Advisory Model

Direct clinical operations oversight for preclinical biopharma startups and emerging innovators needing expert protocol design or data auditing without adding permanent executive headcount.

  • 1099 Consulting Agreement
  • Predictable Flat Hourly Billing
  • Direct M.D. Command & Protocol Review
Request Advisory Scope
Track 2

Extended Project Team

Lean Deployment Model

Direct pass-through access to dedicated trial contractors—including biostatisticians, clinical monitors (CRAs), and medical writers—billed transparently at cost plus a lean management fee.

  • Direct Pass-Through Billing
  • Hand-Selected Contractor Talent
  • Zero Opaque Invoicing Traps
Build Extended Team
Track 3

Milestone Contract Billing

Fixed-Price Project Blocks

Structured, deliverable-based execution for defined clinical trial phases (Phase I–IV) and formal FDA submissions (510(k), PMA, IND), ensuring complete budget predictability.

  • Fixed-Price Project Block Execution
  • Mapped Strictly to Audit Milestones
  • Audit-Proof Compliance Packages
Initiate Trial Scope
Operational Scope

Regulatory Auditing & Execution Pillars

High-integrity clinical execution designed to shield sponsors from FDA delays.

Regulatory Compliance Auditing

Dissecting foreign specs, technical files, and clinical outputs to verify signal precision and eliminate gaps before FDA submission.

  • FDA Pre-Submission Readiness
  • Orphan Drug & Small Business Waivers
  • Signal & Endpoint Precision Audits

Protocol Architecture & FDA Submissions

Designing adaptive trial protocols, statistical analysis plans (SAP), and regulatory dossiers for FDA 510(k), PMA, and IND clearances.

  • FDA 510(k), PMA, & IND Filings
  • Human Physiology & Safety Protocols
  • Target Endpoint Selection

Clinical Operations & Site Liaison

On-the-ground site liaison management across South Florida and Boston-Worcester clinical networks to ensure primary data purity.

  • Pre-Screened Investigator Networks
  • Risk-Based CRA Site Monitoring
  • Rapid CTA & Budget Contracting

Phytochemistry & Natural Product R&D

Applying academic chemistry methodologies to isolate, synthesize, and validate active botanical compounds for commercial applications.

  • Botanical Extractions & Synthesis
  • Active Compound Isolation
  • Bioactive Validation Assays

Data Integrity & Source Auditing

Protecting source data purity through rigorous oversight, ensuring zero exploratory bias and full CDISC/SDTM formatting.

  • 21 CFR Part 11 Validation
  • Data Dignity Enforcement
  • Source Data Verification (SDV)

Stalled & Neglected Asset Rescue

Re-engineering deprioritized biopharma assets and neglected medical devices through advanced computational modeling and AI.

  • Post-Hoc Signal Re-Analysis
  • Repurposing Feasibility Review
  • Fast-Track Clinical Pivots
Sponsor Proposal Gateway

Request Proposal or Regulatory Audit

Submissions route directly to 01_Commercial_Leads_CRO_Services